Albert Bourla, Pfizer CEO (John Thys, Pool via AP Images)
No more business as usual: Pfizer, Bayer and Sanofi step up actions against Russia amid growing pressure to exit
As the Russian invasion of Ukraine enters its third week, pharma — just like a host of other industries — is feeling a growing pressure to get …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
